Barclays raised the firm’s price target on Becton Dickinson (BDX) to $279 from $278 and keeps an Overweight rating on the shares. The firm says ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

American medical technology (MedTech) company Becton Dickinson (BDX) plans to split from its bioscience and diagnostic ...

Activist Starboard took a position in Becton Dickinson, calling for the company to sell its life sciences business. The ...

The continued solid uptake of BD's products is expected to have driven fiscal first-quarter revenues despite transitory ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

BD (NYSE: BDX) announced that its board unanimously authorized management to pursue the separation of its Life Sciences ...

In a notable performance, Becton Dickinson and Co. (NYSE:BDX) stock achieved a 52-week high, reaching a price level of $248.61. According to InvestingPro data, the medical technology giant, with a ...

At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com or by phone at 1-800-839-2486 for domestic calls and area ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...